Predictive performance of physiologically based kinetic (PBK) models based on in-silico/in vitro-in vivo extrapolation (IS/IVIVE)

被引:0
|
作者
Kalra, P. [1 ]
Zhou, H. [1 ]
Lawless, M. [1 ]
机构
[1] Simulat Plus, Lancaster, PA USA
关键词
D O I
暂无
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
P22-40
引用
收藏
页码:S259 / S260
页数:2
相关论文
共 50 条
  • [41] Evaluation of an integrated in vitro-in silico PBPK (physiologically based pharmacokinetic) model to provide estimates of human bioavailability
    Cai, HL
    Stoner, C
    Reddy, A
    Freiwald, S
    Smith, D
    Winters, R
    Stankovic, C
    Surendran, N
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2006, 308 (1-2) : 133 - 139
  • [42] Next generation physiologically based kinetic (NG-PBK) models in support of regulatory decision making
    Paini A.
    Leonard J.A.
    Joossens E.
    Bessems J.G.M.
    Desalegn A.
    Dorne J.L.
    Gosling J.P.
    Heringa M.B.
    Klaric M.
    Kliment T.
    Kramer N.I.
    Loizou G.
    Louisse J.
    Lumen A.
    Madden J.C.
    Patterson E.A.
    Proença S.
    Punt A.
    Setzer R.W.
    Suciu N.
    Troutman J.
    Yoon M.
    Worth A.
    Tan Y.M.
    Computational Toxicology, 2019, 9 : 61 - 72
  • [43] Reply to "Comment on 'In Silico Modeling of Gastrointestinal Drug Absorption: Predictive Performance of Three Physiologically Based Absorption Models'"
    Sjogren, Erik
    Thorn, Helena
    Tannergren, Christer
    MOLECULAR PHARMACEUTICS, 2017, 14 (01) : 340 - 343
  • [44] Comment on "In Silico Modeling of Gastrointestinal Drug Absorption: Predictive Performance of Three Physiologically-Based Absorption Models"
    Turner, David B.
    Liu, Bo
    Patel, Nikunjkumar
    Pathak, Shriram M.
    Polak, Sebastian
    Jamei, Masoud
    Dressman, Jennifer
    Rostami-Hodjegan, Amin
    MOLECULAR PHARMACEUTICS, 2017, 14 (01) : 336 - 339
  • [45] Prediction of human cardiotoxicity of methadone by a combined in vitro - physiologically based kinetic (PBK) modelling- based reverse dosimetry approach
    Shi, M.
    Strikwold, M.
    Rietjens, I. M. C. M.
    Bouwmeester, H.
    TOXICOLOGY LETTERS, 2019, 314 : S154 - S154
  • [46] Integration of mechanism-based in vitro methods and quantitative in vitro-in vivo extrapolation (QIVIVE) modelling for prediction of nephrotoxicity
    Mally, A.
    Birk, B.
    DiFiore, S.
    Ellinger, B.
    Jarzina, S.
    Taverne, F.
    Kramer, N.
    TOXICOLOGY LETTERS, 2018, 295 : S27 - S27
  • [47] Prediction of in vivo developmental toxicity of all-trans-retinoic acid based on in vitro toxicity data and in silico physiologically based kinetic modeling
    Louisse, Jochem
    Bosgra, Sieto
    Blaauboer, Bas J.
    Rietjens, Ivonne M. C. M.
    Verwei, Miriam
    ARCHIVES OF TOXICOLOGY, 2015, 89 (07) : 1135 - 1148
  • [48] Prediction of in vivo developmental toxicity of all-trans-retinoic acid based on in vitro toxicity data and in silico physiologically based kinetic modeling
    Jochem Louisse
    Sieto Bosgra
    Bas J. Blaauboer
    Ivonne M. C. M. Rietjens
    Miriam Verwei
    Archives of Toxicology, 2015, 89 : 1135 - 1148
  • [49] Characterising applicability domains of generic in vitro distribution kinetic and physiologically based kinetic models
    Kramer, N.
    Paini, A.
    Proenca, S.
    Geci, R.
    Yang, H.
    Schaller, S.
    TOXICOLOGY LETTERS, 2022, 368 : S68 - S68
  • [50] Advances in In-Silico based Predictive In-Vivo Profiling of Novel Potent β-Glucuronidase Inhibitors
    Yousuf, Maria
    CURRENT CANCER DRUG TARGETS, 2019, 19 (11) : 906 - 918